CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.
(Q45984095)
scientific article published in November 2006
scientific article published in November 2006
Language:
Current Data About
CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.
other details
description | scientific article published in November 2006 |
External Links
(P356) |
10.1158/0008-5472.CAN-06-0160
|
(P698) |
17108138
|